Inhibitory effects of cordycepin (3′-deoxyadenosine), a component of cordyceps militaris, on human platelet aggregation induced by thapsigargin

Journal of Microbiology and Biotechnology

Volumn 17, Issue 7, 2007, Pages 1134-1138

  Cho, Hyun Jeong ^a,d   Cho, Jae Youl ^b   Rhee, Man Hee ^c   Kim, Hyeong Soo ^a   Lee, Hyun Sub ^a   Park, Hwa Jin ^a  

^a Inje University   (South Korea)

^b Kangwon National University   (South Korea)

^c Kyungpook National University   (South Korea)

^d DreamPharma   (South Korea)

Author keywords

Antiplatelet activity; cGMP; Cordycepin; Intracellular Ca2+

Indexed keywords

CALCIUM ION; CORDYCEPIN; CYCLIC GMP; THAPSIGARGIN; TUMOR PROMOTER;

ANTICOAGULATION; ARTICLE; CALCIUM CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORDYCEPS; CORDYCEPS MILITARIS; HUMAN; HUMAN CELL; THROMBOCYTE AGGREGATION;

CORDYCEPS; DEOXYADENOSINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; THAPSIGARGIN;

CORDYCEPS MILITARIS;

EID: 34547976762     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Cunningham, K. G., W. Manson, F. S. Spring, and S. A. Hutchinson. 1950. Cordycepin, a metabolic product isolated from cultures of Cordyceps militaris (Linn.) Link. Nature 166: 949.
2. 2+ signaling in the brain. J. Neurochem. 64: 953-960.
3. 2+ entry pathways activated by the tumor promoter thapsigargin in human platelets. Biochim. Biophys. Acta 1220: 37-41.
4. Haslam, R. J., M. M. Davidson, and J. V. Desjardins. 1978. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP. Biochem. J. 176: 83-95.
5. Hubbell, H. R., E. C. Pequignot, D. H. Willis, C. Lee, and R. J. Suhadolnik. 1985. Differential antiproliferative actions of 2′,5′ oligo A trimer core and its cordycepin analogue on human tumor cells. Int. J. Cancer 36: 389-394.
6. 2+ without generation of inositol phosphates in NG115-401L neuronal cells. Biochem. J. 253: 81-86.
7. Jang, E. K., J. E. Azzam, N. T. Dickinson, M. M. Davidson, and R. J. Haslam. 2002. Roles for both cyclic GMP and cyclic AMP in the inhibition of collagen-induced platelet aggregation by nitroprusside. Br. J. Haematol. 117: 664-675.
8. Kaibuchi, K., K. Sano, M. Hoshijima, Y. Takai, and Y. Nishizuka. 1982. Phosphatidylinositol turnover in platelet activation; calcium mobilization and protein phosphorylation. Cell Calcium 3: 323-335.
9. Londos, C. and J. Wolff. 1977. Two distinct adenosine-sensitive sites on adenylate cyclase. Proc. Natl. Acad. Sci. USA 74: 5482-5486.
10. 2+ and on aggregation of human platelets. Eur. J. Pharmacol. 245: 281-284.
11. 2+ entry in human platelets. Biochem. J. 285: 341-344.
12. Saxena, S. P., A. McNicol, A. B. Becker, L. J. Brandes, O. Thastrup, and J. M. Gerrard. 1992. Biochemical and ultrastructural studies suggest that the effects of thapsigargin on human platelets are mediated by changes in intracellular calcium but not by intracellular histamine. Thromb. Haemost. 68: 714-718.
13. Schaeffer, J. and M. P. Blaustein. 1989. Platelet free calcium concentrations measured with fura-2 are influenced by the transmembrane sodium gradient. Cell Calcium 10: 101-113.
14. Schwartz, S. M., R. L. Heimark, and M. W. Majesky. 1990. Developmental mechanisms underlying pathology of arteries. Physiol. Rev. 70: 1177-1209.
15. Son, D. J., Y. H. Park, Y. M. Kim, N. H. Chung, and H. S. Lee. 2005. Antiplatelet activity of Thujopsis dolabrata var. hondai-derived component against platelet aggregation. J. Microbiol. Biotechnol. 15: 425-427.
16. Wang, G. R., Y. Zhu, P. V. Halushka, T. M. Lincoln, and M. E. Mendelsohn. 1998. Mechanism of platelet inhibition by nitric oxide: In vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase. Proc. Natl. Acad. Sci. USA 95: 4888-4893.
17. Won, S. Y. and E. H. Park. 2005. Anti-inflammatory and related pharmacological activities of cultured mycelia and fruiting bodies of Cordyceps militaris. J. Ethnopharmacol. 96: 555-561.
18. Xu, B., A. Siephens, G. Kirschenheuter, A. F. Greslin, X. Cheng, J. Sennelo, M. Cattaneo, M. L. Zighetti, A. Chen, S. A. Kim, H. S. Kim, N. Bischofberger, G. Cook, and K. A. Jacobson. 2002. Acyclic analogues of adenosine bisphosphates as P2Y receptor antagonists: Phosphate substitution leads to multiple pathways of inhibition of platelet aggregation. J. Med. Chem. 45: 5694-5709.
19. Yang, B. K., J. Y. Ha, S. C. Jong, S. Das, J. W. Yun, Y. S. Lee, J. W. Choi, and C. H. Song. 2000. Production of exopolymers by submerged mycelial culture of Cordyceps militaris and its hypolipidemic effect. J. Microbiol. Biotechnol. 10: 784-788.
20. Yu, K. W, H. J. Suh, S. H. Bae, C. S. Lee, S. H. Kim, and C. S. Yoon. 2001. Chemical properties and physiological activities of stromata of Cordyceps militaris. J. Microbiol. Biotechnol. 11: 266-274.
21. Yu, R., L. Song, Y. Zhao, W. Bin, L. Wang, H. Zhang, Y. Wu, W. Ye, and X. Yao. 2004. Isolation and biological properties of polysaccharide CPS-1 from cultured Cordyceps militaris. Fitoterapia 75: 465-472.